FindTrial
Sign In

Treatment of Hypertension through Aswagandha Churna

A Nidanatmaka (Epidemiological) Study on Raktagata Vata (Hypertension) and An Upashayatmaka (Therapeutic) Study to Evaluate The Efficacy of Aswagandha Churna.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037162
Enrollment
30
Registered
2021-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I00-I99- Diseases of the circulatory system

Interventions

None listed

Sponsors

Government Ayurvedic College and Hospital Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical symptoms of Raktagata Vata given in samhitas will be taken.

Exclusion criteria

Exclusion criteria: Pregnant women and lactating mother. Patient suffering from genetical and congenital disease. Patient having BP more than 200/100mmHg are excluded. Patient having any complication like Diabetes and cancer.

Design outcomes

Primary

MeasureTime frame
Improvement in sign and symptom of Raktagata vataTimepoint: 2 months—

Secondary

MeasureTime frame
Improvement in Raktagata vata Improvement in sign and symptoms of Raktagata vataTimepoint: 2 months 2 months—

Countries

India

Contacts

Public ContactDr Archana Kumari Rai

Government Ayurvedic College and Hospital Patna

singh.amrendra70@yahoo.co.in7013506981

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026